Jezová D, Oliver C, Jurcovicová J
Institute of Experimental Endocrinology, Slovak Academy of Sciences, Bratislava, Czechoslovakia.
Neuroendocrinology. 1991 Nov;54(5):488-92. doi: 10.1159/000125942.
The aim of this study was to elucidate the effects of N-methyl-D-aspartic acid (NMDA) receptor stimulation on the release of several hormones known to be activated during stress. The experiments were performed in conscious freely moving cannulated rats. Systemic administration of N-methyl-D,L-aspartic acid (NMA) and of NMDA in low doses (2.5-10 mg/kg i.p.) was found to induce a dose-related stimulation of adrenocorticotropin (ACTH) release. NMA-induced ACTH release was reduced by administration of an NMDA receptor antagonist (D,L-2-amino-5-phosphonovaleric acid). NMDA was much more potent in activating ACTH release than the racemic form of the amino acid, NMA. In the dose range used, both NMA and NMDA failed to influence prolactin release. With the exception of a small increase in epinephrine concentration in response to the highest dose of NMDA (10 mg/kg), no changes in plasma catecholamines were observed. The data indicate that NMA and NMDA administered in low doses trigger ACTH release without induction of a nonspecific stress response.
本研究的目的是阐明N-甲基-D-天冬氨酸(NMDA)受体刺激对应激期间已知被激活的几种激素释放的影响。实验在有意识的自由活动插管大鼠中进行。发现全身给予N-甲基-D,L-天冬氨酸(NMA)和低剂量(2.5-10mg/kg腹腔注射)的NMDA可诱导促肾上腺皮质激素(ACTH)释放的剂量相关刺激。给予NMDA受体拮抗剂(D,L-2-氨基-5-磷酸缬氨酸)可减少NMA诱导的ACTH释放。在激活ACTH释放方面,NMDA比氨基酸的外消旋形式NMA更有效。在所使用的剂量范围内,NMA和NMDA均未影响催乳素释放。除了对最高剂量的NMDA(10mg/kg)有肾上腺素浓度的小幅增加外,未观察到血浆儿茶酚胺的变化。数据表明,低剂量给予的NMA和NMDA可触发ACTH释放而不诱导非特异性应激反应。